Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 482

Results For "NAL"

6624 News Found

University of Nebraska Medical Center and ANANDA Scientific announce USFDA approval
Biotech | May 17, 2022

University of Nebraska Medical Center and ANANDA Scientific announce USFDA approval

The study will evaluate the effectiveness of Nantheia ATL5, an investigational drug using cannabidiol in ANANDA’s proprietary delivery technology


BDR Pharma receives Rs. 685 crore of PE investment
News | May 17, 2022

BDR Pharma receives Rs. 685 crore of PE investment

Multiples is the first private equity (PE) investor in the company


BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca
Biotech | May 17, 2022

BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI


Aster DM Healthcare partners with Skye Air Mobility for drone delivery
News | May 17, 2022

Aster DM Healthcare partners with Skye Air Mobility for drone delivery

Following the successful completion of the 7day BVLOS trials, Skye Air targets to undertake approximately 80 flights, each carrying blood samples and medicines for Aster Clinics


Takeda launches Adynovate for Hemophilia patients in India
News | May 16, 2022

Takeda launches Adynovate for Hemophilia patients in India

Adynovate in combination with Mypkfit offers personalized treatment and enables HCPs and patients to monitor factor levels from home and help achieve optimum QOL outcomes


Boehringer Ingelheim’s treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis
Biotech | May 16, 2022

Boehringer Ingelheim’s treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis

Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer Ingelheim’s leadership in lung fibrosis and will be further investigated in a phase III clinical trial program


Antengene announces commercial availability of Xpovio in China
Biotech | May 16, 2022

Antengene announces commercial availability of Xpovio in China

The drug will be available in 600 hospitals and 105 DTPs


Inmagene receives USFDA IND clearance for a third-generation BTK inhibitor
Biotech | May 16, 2022

Inmagene receives USFDA IND clearance for a third-generation BTK inhibitor

It is developing the drug candidate to potentially treat immunological diseases


Bharat Rubber Works to exhibit at PharmaPack Europe 2022
Packaging | May 16, 2022

Bharat Rubber Works to exhibit at PharmaPack Europe 2022

Pharmapack offers the platform that enables Bharat Rubber Works to convey its story while simultaneously demonstrating the extraordinary advancements by the company in the field of pharmaceutical packaging


New report highlights lack of access to assistive technology
Healthcare | May 16, 2022

New report highlights lack of access to assistive technology

WHO and UNICEF call on governments, industry, donors and civil society to fund and prioritize access to assistive products